154 related articles for article (PubMed ID: 38262638)
1. Randomised controlled trial of early magnetically controlled capsule endoscopy for the prevention of gastrointestinal bleeding in patients at high bleeding risk scheduled for percutaneous coronary intervention: MACE-GPS study protocol.
Li M; Liu R; Wu Y
BMJ Open; 2024 Jan; 14(1):e077852. PubMed ID: 38262638
[TBL] [Abstract][Full Text] [Related]
2. Optimal antiplatelet therapy for prevention of gastrointestinal injury evaluated by ANKON magnetically controlled capsule endoscopy: Rationale and design of the OPT-PEACE trial.
Li Y; Wang X; Bao D; Liao Z; Li J; Han X; Wang H; Xu K; Li Z; Stone GW; Han Y
Am Heart J; 2020 Oct; 228():8-16. PubMed ID: 32745734
[TBL] [Abstract][Full Text] [Related]
3. Alirocumab effect on preventing periprocedural ischaemic events in coronary heart disease patients undergoing coronary stenting (APPEASE trial): study protocol of a multicentre, open-label, randomised controlled trial.
Huang Z; Zhuang X; Zhang S; Huang Y; Yuan L; Lin A; Tang L; Xiong Z; Christopher O; Chen Y; Wu B; Ling Y; Li S; Jie Q; Xiong L; Qian X; Liao X; Liu J
BMJ Open; 2023 Jul; 13(7):e072541. PubMed ID: 37433737
[TBL] [Abstract][Full Text] [Related]
4. Magnetically Controlled Capsule Endoscopy for Assessment of Antiplatelet Therapy-Induced Gastrointestinal Injury.
Han Y; Liao Z; Li Y; Zhao X; Ma S; Bao D; Qiu M; Deng J; Wang J; Qu P; Jiang C; Jia S; Yang S; Ru L; Feng J; Gao W; Huang Y; Tao L; Han Y; Yang K; Wang X; Zhang W; Wang B; Li Y; Yang Y; Li J; Sheng J; Ma Y; Cui M; Ma S; Wang X; Li Z; Stone GW
J Am Coll Cardiol; 2022 Jan; 79(2):116-128. PubMed ID: 34752902
[TBL] [Abstract][Full Text] [Related]
5. Progression of Gastrointestinal Injury During Antiplatelet Therapy After Percutaneous Coronary Intervention: A Secondary Analysis of the OPT-PEACE Randomized Clinical Trial.
He C; Li Y; Jiang X; Jiang MN; Zhao XX; Ma SR; Bao D; Qiu MH; Deng J; Wang JH; Qu P; Jiang CM; Jia SB; Yang SQ; Ru LS; Feng J; Gao W; Huang YH; Tao L; Han Y; Yang K; Wang XY; Zhang WJ; Wang BM; Li Y; Yang YL; Li JX; Sheng JQ; Ma YT; Cui M; Ma SC; Wang XZ; Li ZS; Liao Z; Han YL; Stone GW
JAMA Netw Open; 2023 Nov; 6(11):e2343219. PubMed ID: 37976067
[TBL] [Abstract][Full Text] [Related]
6. Effect of dexamethasone in patients with ARDS and COVID-19 - prospective, multi-centre, open-label, parallel-group, randomised controlled trial (REMED trial): A structured summary of a study protocol for a randomised controlled trial.
Maláska J; Stašek J; Duška F; Balík M; Máca J; Hruda J; Vymazal T; Klementová O; Zatloukal J; Gabrhelík T; Novotný P; Demlová R; Kubátová J; Vinklerová J; Svobodník A; Kratochvíl M; Klučka J; Gál R; Singer M;
Trials; 2021 Mar; 22(1):172. PubMed ID: 33648568
[TBL] [Abstract][Full Text] [Related]
7. Efficacy and tolerance of early administration of tranexamic acid in patients with cirrhosis presenting with acute upper gastrointestinal bleeding: a study protocol for a multicentre, randomised, double-blind, placebo-controlled trial (the EXARHOSE study).
Heidet M; Amathieu R; Audureau E; Augusto O; Nicolazo de Barmon V; Rialland A; Schmitz D; Pierrang F; Marty J; Chollet-Xémard C; Thirion O; Jacob L
BMJ Open; 2018 Aug; 8(8):e021943. PubMed ID: 30099397
[TBL] [Abstract][Full Text] [Related]
8. Quantitative coronary angiography versus intravascular ultrasound guidance for drug-eluting stent implantation (GUIDE-DES): study protocol for a randomised controlled non-inferiority trial.
Lee PH; Hong SJ; Kim HS; Yoon YW; Lee JY; Oh SJ; Kang SJ; Kim YH; Park SW; Lee SW; Lee CW;
BMJ Open; 2022 Jan; 12(1):e052215. PubMed ID: 35027418
[TBL] [Abstract][Full Text] [Related]
9. Enoxaparin for primary thromboprophylaxis in ambulatory patients with coronavirus disease-2019 (the OVID study): a structured summary of a study protocol for a randomized controlled trial.
Barco S; Bingisser R; Colucci G; Frenk A; Gerber B; Held U; Mach F; Mazzolai L; Righini M; Rosemann T; Sebastian T; Spescha R; Stortecky S; Windecker S; Kucher N
Trials; 2020 Sep; 21(1):770. PubMed ID: 32907635
[TBL] [Abstract][Full Text] [Related]
10. Randomised controlled trial to investigate optimal antithrombotic therapy in patients with non-valvular atrial fibrillation undergoing percutaneous coronary intervention: a study protocol of the OPTIMA-AF trial.
Sotomi Y; Kozuma K; Kashiwabara K; Higuchi Y; Ando K; Morino Y; Ako J; Tanabe K; Muramatsu T; Nakazawa G; Hikoso S; Sakata Y;
BMJ Open; 2021 Dec; 11(12):e048354. PubMed ID: 34907043
[TBL] [Abstract][Full Text] [Related]
11. Prospective multicentre open-label randomised controlled trial of 3-month versus 12-month dual antiplatelet therapy after implantation of the new generation biodegradable polymer sirolimus TARGET-eluting coronary stent: protocol of the TARGET DAPT trial.
Yang H; Zhang F; Yang J; Zheng M; Cao R; Dai Y; Li C; Yao K; Qian J; Ge J;
BMJ Open; 2019 Dec; 9(12):e033774. PubMed ID: 31852711
[TBL] [Abstract][Full Text] [Related]
12. Very early invasive angiography versus standard of care in higher-risk non-ST elevation myocardial infarction: study protocol for the prospective multicentre randomised controlled RAPID N-STEMI trial.
Kite TA; Banning AS; Ladwiniec A; Gale CP; Greenwood JP; Dalby M; Hobson R; Barber S; Parker E; Berry C; Flather MD; Curzen N; Banning AP; McCann GP; Gershlick AH
BMJ Open; 2022 May; 12(5):e055878. PubMed ID: 35504645
[TBL] [Abstract][Full Text] [Related]
13. A randomized controlled trial comparing efficacy of early video capsule endoscopy with standard of care in the approach to nonhematemesis GI bleeding (with videos).
Marya NB; Jawaid S; Foley A; Han S; Patel K; Maranda L; Kaufman D; Bhattacharya K; Marshall C; Tennyson J; Cave DR
Gastrointest Endosc; 2019 Jan; 89(1):33-43.e4. PubMed ID: 29935143
[TBL] [Abstract][Full Text] [Related]
14. Coagulopathy of hospitalised COVID-19: A Pragmatic Randomised Controlled Trial of Therapeutic Anticoagulation versus Standard Care as a Rapid Response to the COVID-19 Pandemic (RAPID COVID COAG - RAPID Trial): A structured summary of a study protocol for a randomised controlled trial.
Sholzberg M; Tang GH; Negri E; Rahhal H; Kreuziger LB; Pompilio CE; James P; Fralick M; AlHamzah M; Alomran F; Tseng E; Lim G; Lillicrap D; Carrier M; Áinle FN; Beckett A; da Costa BR; Thorpe K; Middeldorp S; Lee A; Cushman M; Jüni P
Trials; 2021 Mar; 22(1):202. PubMed ID: 33691765
[TBL] [Abstract][Full Text] [Related]
15. Intravenous
Teutsch B; Váncsa S; Farkas N; Szakács Z; Vörhendi N; Boros E; Szabó I; Hágendorn R; Alizadeh H; Hegyi P; Erőss B
BMJ Open; 2023 Mar; 13(3):e063554. PubMed ID: 36918236
[TBL] [Abstract][Full Text] [Related]
16. Double-blind, placebo-controlled randomised clinical trial to evaluate the effect of ASPIRIN discontinuation after left atrial appendage occlusion in atrial fibrillation: protocol of the ASPIRIN LAAO trial.
Chen M; Wang Q; Sun J; Zhang PP; Li W; Mo BF; Chen TZ; Tang X; Li YG;
BMJ Open; 2021 Mar; 11(3):e044695. PubMed ID: 33722871
[TBL] [Abstract][Full Text] [Related]
17. Management of Renin-Angiotensin-Aldosterone System blockade in patients admitted to hospital with confirmed coronavirus disease (COVID-19) infection (The McGill RAAS-COVID- 19): A structured summary of a study protocol for a randomized controlled trial.
Aflaki M; Flannery A; Ferreira JP; Cheng MP; Kronfli N; Marelli A; Zannad F; Brophy J; Afillalo J; Huynh T; Giannetti N; Bessissow A; Ezekowitz JA; Lopes RD; Ambrosy AP; Craig M; Sharma A
Trials; 2021 Feb; 22(1):115. PubMed ID: 33546734
[TBL] [Abstract][Full Text] [Related]
18. Repair of Acute Respiratory Distress Syndrome by Stromal Cell Administration in COVID-19 (REALIST-COVID-19): A structured summary of a study protocol for a randomised, controlled trial.
Gorman E; Shankar-Hari M; Hopkins P; Tunnicliffe WS; Perkins GD; Silversides J; McGuigan P; Jackson C; Boyle R; McFerran J; McDowell C; Campbell C; McFarland M; Smythe J; Thompson J; Williams B; Curley G; Laffey JG; Clarke M; O'Kane C; McAuley DF
Trials; 2020 Jun; 21(1):462. PubMed ID: 32493473
[TBL] [Abstract][Full Text] [Related]
19. Reconvalescent plasma/camostat mesylate in early SARS-CoV-2 Q-PCR positive high-risk individuals (RES-Q-HR): a structured summary of a study protocol for a randomized controlled trial.
Keitel V; Jensen B; Feldt T; Fischer JC; Bode JG; Matuschek C; Bölke E; Budach W; Plettenberg C; Scheckenbach K; Kindgen-Milles D; Timm J; Müller L; Kolbe H; Stöhr A; Calles C; Hippe A; Verde P; Spinner CD; Schneider J; Wolf T; Kern WV; Nattermann J; Zoufaly A; Ohmann C; Luedde T;
Trials; 2021 May; 22(1):343. PubMed ID: 34001215
[TBL] [Abstract][Full Text] [Related]
20. A Randomized Open label Phase-II Clinical Trial with or without Infusion of Plasma from Subjects after Convalescence of SARS-CoV-2 Infection in High-Risk Patients with Confirmed Severe SARS-CoV-2 Disease (RECOVER): A structured summary of a study protocol for a randomised controlled trial.
Janssen M; Schäkel U; Djuka Fokou C; Krisam J; Stermann J; Kriegsmann K; Haberbosch I; Novotny JP; Weber S; Vehreschild M; Bornhäuser M; Bullinger L; Schmitt M; Liebregts T; Dreger P; Lorenz HM; Plaszczyca A; Bartenschlager R; Müller B; Kräusslich HG; Halama N; Jäger D; Schlenk RF; Leo A; Meuer S; Weigand MA; Motsch J; Merle U; Denkinger CM; Müller-Tidow C
Trials; 2020 Oct; 21(1):828. PubMed ID: 33023671
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
